Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net loss	$ (37,738)	$ (9,065)
Adjustments to reconcile net loss to net cash provided by (used in) provided by operating activities:
Depreciation	7,101	6,783
Amortization of intangible assets	8,425	7,073
Amortization of operating lease right-of-use assets	4,317
Provision for doubtful accounts	401	515
Stock-based compensation	8,834	6,825
Deferred income taxes	357	(25)
Non-cash restructuring and related charges	3,839
Unrealized/realized gain on equity investment		(154)
Non-cash interest expense	904	995
Other	(78)	(172)
Changes in operating assets and liabilities, net of acquisitions
Accounts receivable	33,490	46,661
Inventories	(2,108)	8,287
Prepaid expenses and other assets	(486)	(7,814)
Accounts payable	(11,198)	(31,251)
Accrued compensation and benefits	(10,277)	(13,964)
Operating lease liabilities	(4,631)
Deferred revenue	2,001	9,374
Other current and long-term liabilities	(3,355)	10,262
Net cash (used in) provided by operating activities	(202)	34,330
Cash flows from investing activities:
Capital expenditures	(5,239)	(7,417)
Business acquisitions, net of cash acquired	(219,458)
Maturities and sales of investments	15,503	727
Net cash used in investing activities	(209,194)	(6,690)
Cash flows from financing activities:
Borrowings under Term Loan	199,500
Repayments of debt	(20,099)	(12,466)
Loan fees on borrowings	(10,515)	(273)
Proceeds from issuance of common stock, net of tax withholding	4,136	7,137
Contingent consideration obligations	(635)	(1,577)
Deferred payments on an acquisition	(1,000)	(1,000)
Net cash provided by (used in) financing activities	171,387	(8,179)
Foreign currency effect on cash	(229)	(433)
Net (decrease) increase in cash	(38,238)	19,028
Cash and cash equivalents at beginning of period	169,607	121,139
Cash and cash equivalents at end of period	$ 131,369	$ 140,167